Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT06578949 · COMPLETED
Trial details
- NCT number
- NCT06578949
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2025-05-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.